Drugs Information: Laronidase
Basic Information
|
||
| ID | DDInter1025 | |
| Drug Type | biotech | |
| Molecular Formula | C3160H4848N898O881S12 | |
| Molecular Weight | - | |
| Description | Laronidase is a form of recombinant human alpha-L-iduronidase used to treat Hurler and Hurler-Scheie forms of mucopolysaccharidosis, a genetic deficiency of alpha-L-iduronidase. | |
| ATC Classification | A16AB05 | |
| IUPAC Name | None | |
| InChI | None | |
| InChI Key | None | |
| Canonical SMILES | None | |
| Useful Links | DrugBank | |
Interactions with Laronidase
| Severity level | ID | Name | Mechanism | Detail |
|---|